date:Jun 22, 2012
Consumption of proprietary whey-derived bioactive peptides (NOP-47, Glanbia Nutritionals) resulted in an increase in flow-mediated dilation (FMD) of between 1 and 1.5%, report researchers from the University of Connecticut in theBritish Journal of Nutrition.
While the clinical significance of the results is uncertain, Dr Jeff Volek and his co-workers note that decreased FMD is reported to be a predictor of future adverse cardiovascular events, with every 1% decrease in FMD associated with a 1